- Home
- LITB vs BCTX Comparison
LITB vs BCTX Comparison
Compare LITB & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- BCTX
- Stock Information
- Founded
- LITB 2007
- BCTX 2014
- Country
- LITB Singapore
- BCTX Canada
- Employees
- LITB N/A
- BCTX N/A
- Industry
- LITB Catalog/Specialty Distribution
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- LITB Consumer Discretionary
- BCTX Health Care
- Exchange
- LITB Nasdaq
- BCTX Nasdaq
- Market Cap
- LITB 21.1M
- BCTX 23.5M
- IPO Year
- LITB N/A
- BCTX N/A
- Fundamental
- Price
- LITB $1.31
- BCTX $2.02
- Analyst Decision
- LITB
- BCTX Strong Buy
- Analyst Count
- LITB 0
- BCTX 1
- Target Price
- LITB N/A
- BCTX $32.00
- AVG Volume (30 Days)
- LITB 10.8K
- BCTX 995.1K
- Earning Date
- LITB 08-01-2025
- BCTX 06-16-2025
- Dividend Yield
- LITB N/A
- BCTX N/A
- EPS Growth
- LITB N/A
- BCTX N/A
- EPS
- LITB 0.08
- BCTX N/A
- Revenue
- LITB $231,136,000.00
- BCTX N/A
- Revenue This Year
- LITB N/A
- BCTX N/A
- Revenue Next Year
- LITB N/A
- BCTX N/A
- P/E Ratio
- LITB $16.67
- BCTX N/A
- Revenue Growth
- LITB N/A
- BCTX N/A
- 52 Week Low
- LITB $0.91
- BCTX $1.97
- 52 Week High
- LITB $4.98
- BCTX $29.40
- Technical
- Relative Strength Index (RSI)
- LITB 57.98
- BCTX 22.76
- Support Level
- LITB $1.22
- BCTX $1.97
- Resistance Level
- LITB $1.34
- BCTX $3.00
- Average True Range (ATR)
- LITB 0.08
- BCTX 0.19
- MACD
- LITB 0.02
- BCTX -0.09
- Stochastic Oscillator
- LITB 82.76
- BCTX 4.20
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.